Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parvez S Mantry

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Health Services Research and Managerial Epidemiology|June 26, 2019
A Cross-Sectional Study of Stress and the Perceived Style of Decision-Making in Clinicians and Patients With CancerElaina Vivian, Hellen Oduor, Laurie Lundberg, et al.
Transplantation|December 24, 2005
Liver transplantation in sickle cell anemia: a case of acute sickle cell intrahepatic cholestasis and a case of sclerosing cholangitisMatthew M Baichi, Razi M Arifuddin, Parvez S Mantry, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single centerRucha M Shah, Sarah Sheikh, Jimmy Shah, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 2, 2017
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trialsEdward Tam, Anne F Luetkemeyer, Parvez S Mantry, et al.
Gastroenterology|March 16, 2016
Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal DiseasePaul J Pockros, K Rajender Reddy, Parvez S Mantry, et al.
Journal of Hepatology|October 10, 2020
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosisCatherine Frenette, Zeid Kayali, Edward Mena, et al.
Kidney International Reports|February 19, 2019
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney DiseaseEric Lawitz, Edward Gane, Eric Cohen, et al.
The New England Journal of Medicine|November 12, 2014
An interferon-free antiviral regimen for HCV after liver transplantationPaul Y Kwo, Parvez S Mantry, Eoin Coakley, et al.
Hepatology (Baltimore, Md.)|November 8, 2024
Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trialBenjamin J Bruno, Joshua C Weavil, Jonathan Ogle, et al.
Hepatology (Baltimore, Md.)|September 12, 2017
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trialRohit Loomba, Eric Lawitz, Parvez S Mantry, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Health Services Research and Managerial Epidemiology|June 26, 2019
A Cross-Sectional Study of Stress and the Perceived Style of Decision-Making in Clinicians and Patients With CancerElaina Vivian, Hellen Oduor, Laurie Lundberg, et al.
Transplantation|December 24, 2005
Liver transplantation in sickle cell anemia: a case of acute sickle cell intrahepatic cholestasis and a case of sclerosing cholangitisMatthew M Baichi, Razi M Arifuddin, Parvez S Mantry, et al.
Journal of Gastrointestinal Oncology|September 17, 2021
Prognostic factors of unresectable hepatocellular carcinoma treated with yttrium-90 radioembolization: results from a large cohort over 13 years at a single centerRucha M Shah, Sarah Sheikh, Jimmy Shah, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 2, 2017
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir-experienced, NS5A treatment-naïve patients: Findings from two randomized trialsEdward Tam, Anne F Luetkemeyer, Parvez S Mantry, et al.
Gastroenterology|March 16, 2016
Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal DiseasePaul J Pockros, K Rajender Reddy, Parvez S Mantry, et al.
Journal of Hepatology|October 10, 2020
Emricasan to prevent new decompensation in patients with NASH-related decompensated cirrhosisCatherine Frenette, Zeid Kayali, Edward Mena, et al.
Kidney International Reports|February 19, 2019
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney DiseaseEric Lawitz, Edward Gane, Eric Cohen, et al.
The New England Journal of Medicine|November 12, 2014
An interferon-free antiviral regimen for HCV after liver transplantationPaul Y Kwo, Parvez S Mantry, Eoin Coakley, et al.
Hepatology (Baltimore, Md.)|November 8, 2024
Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trialBenjamin J Bruno, Joshua C Weavil, Jonathan Ogle, et al.
Hepatology (Baltimore, Md.)|September 12, 2017
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trialRohit Loomba, Eric Lawitz, Parvez S Mantry, et al.
Pageof 3